Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034653105> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2034653105 endingPage "338" @default.
- W2034653105 startingPage "329" @default.
- W2034653105 abstract "ABSTRACT Human pituitary tumours, obtained at surgery for Cushing's disease and Nelson's syndrome, were extracted and the content and molecular forms of proopiomelanocortin (POMC)-derived peptides determined by radioimmunoassay, gel chromatography, reversed-phase high-performance liquid chromatography (HPLC) and sequence analysis. In the tumours from patients with Cushing's disease the mean concentrations of amidated peptides relative to the total amount of POMC were as follows: α-MSH, 1·7%; amidated γ-MSH (γ 1 -MSH), 8·5% and the peptide linking γ-MSH and ACTH in the precursor (hinge peptide or joining peptide) in its amidated form (HP-N), 17·1%. The same relative concentrations in the tumours from patients with Nelson's syndrome were 8·5% (α-MSH), 7·5% (γ 1 -MSH) and 12·2% (HP-N). More than 95% of the ACTH(1–39) immunoreactivity eluted as synthetic ACTH(1–39) by gel chromatography and HPLC. The remaining ACTH(1–39) immunoreactivity eluted as partly glycosylated high molecular weight forms. All the α-MSH and its glycine-extended precursor ACTH(1–14) were of low molecular weight, mainly non- or mono-acetylated forms, but significant amounts of diacetylated analogues were also present. γ 1 -MSH and γ 2 -MSH immunoreactivities eluted as high molecular weight forms and were partly glycosylated. No low molecular weight forms of γ 1 -MSH or γ 2 -MSH could be detected in the pituitary tumours. Amidated hinge peptide was mainly of the 30 amino acid form. In conclusion, all the molecular forms of the amidated peptides detected in tumours from patients with Cushing's disease and Nelson's syndrome were similar to the molecular forms found in the normal human pituitary. The main difference between the tumours and the normal pituitary was the greater amount of peptides produced, particularly α-MSH and γ 1 -MSH. J. Endocr . (1988) 118, 329–338" @default.
- W2034653105 created "2016-06-24" @default.
- W2034653105 creator A5051823868 @default.
- W2034653105 creator A5082916255 @default.
- W2034653105 date "1988-08-01" @default.
- W2034653105 modified "2023-09-24" @default.
- W2034653105 title "α-Amidated peptides derived from pro-opiomelanocortin in human pituitary tumours" @default.
- W2034653105 doi "https://doi.org/10.1677/joe.0.1180329" @default.
- W2034653105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2844950" @default.
- W2034653105 hasPublicationYear "1988" @default.
- W2034653105 type Work @default.
- W2034653105 sameAs 2034653105 @default.
- W2034653105 citedByCount "5" @default.
- W2034653105 crossrefType "journal-article" @default.
- W2034653105 hasAuthorship W2034653105A5051823868 @default.
- W2034653105 hasAuthorship W2034653105A5082916255 @default.
- W2034653105 hasConcept C126322002 @default.
- W2034653105 hasConcept C134018914 @default.
- W2034653105 hasConcept C176685330 @default.
- W2034653105 hasConcept C179998833 @default.
- W2034653105 hasConcept C185592680 @default.
- W2034653105 hasConcept C2777658017 @default.
- W2034653105 hasConcept C2779281246 @default.
- W2034653105 hasConcept C2779435821 @default.
- W2034653105 hasConcept C2780017199 @default.
- W2034653105 hasConcept C2780090379 @default.
- W2034653105 hasConcept C2780546910 @default.
- W2034653105 hasConcept C2781309135 @default.
- W2034653105 hasConcept C43617362 @default.
- W2034653105 hasConcept C55493867 @default.
- W2034653105 hasConcept C56191518 @default.
- W2034653105 hasConcept C71315377 @default.
- W2034653105 hasConcept C71924100 @default.
- W2034653105 hasConcept C73826308 @default.
- W2034653105 hasConceptScore W2034653105C126322002 @default.
- W2034653105 hasConceptScore W2034653105C134018914 @default.
- W2034653105 hasConceptScore W2034653105C176685330 @default.
- W2034653105 hasConceptScore W2034653105C179998833 @default.
- W2034653105 hasConceptScore W2034653105C185592680 @default.
- W2034653105 hasConceptScore W2034653105C2777658017 @default.
- W2034653105 hasConceptScore W2034653105C2779281246 @default.
- W2034653105 hasConceptScore W2034653105C2779435821 @default.
- W2034653105 hasConceptScore W2034653105C2780017199 @default.
- W2034653105 hasConceptScore W2034653105C2780090379 @default.
- W2034653105 hasConceptScore W2034653105C2780546910 @default.
- W2034653105 hasConceptScore W2034653105C2781309135 @default.
- W2034653105 hasConceptScore W2034653105C43617362 @default.
- W2034653105 hasConceptScore W2034653105C55493867 @default.
- W2034653105 hasConceptScore W2034653105C56191518 @default.
- W2034653105 hasConceptScore W2034653105C71315377 @default.
- W2034653105 hasConceptScore W2034653105C71924100 @default.
- W2034653105 hasConceptScore W2034653105C73826308 @default.
- W2034653105 hasIssue "2" @default.
- W2034653105 hasLocation W20346531051 @default.
- W2034653105 hasLocation W20346531052 @default.
- W2034653105 hasOpenAccess W2034653105 @default.
- W2034653105 hasPrimaryLocation W20346531051 @default.
- W2034653105 hasRelatedWork W2019680422 @default.
- W2034653105 hasRelatedWork W2034653105 @default.
- W2034653105 hasRelatedWork W2036057958 @default.
- W2034653105 hasRelatedWork W2038216785 @default.
- W2034653105 hasRelatedWork W2047771556 @default.
- W2034653105 hasRelatedWork W2063591284 @default.
- W2034653105 hasRelatedWork W2071887381 @default.
- W2034653105 hasRelatedWork W2072048885 @default.
- W2034653105 hasRelatedWork W2076542955 @default.
- W2034653105 hasRelatedWork W2149020661 @default.
- W2034653105 hasVolume "118" @default.
- W2034653105 isParatext "false" @default.
- W2034653105 isRetracted "false" @default.
- W2034653105 magId "2034653105" @default.
- W2034653105 workType "article" @default.